Rituximab for Scleroderma: Does Something Finally Work?
Dr. Kevin Deane reports on a recent study in Rheumatology exploring the utility of rituximab in treating scleroderma. Medscape Rheumatology (Source: Medscape Today Headlines)
Starting Treatment Early Doubles Chance Of Success For People With Diabetes
The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association. The study found that metformin, an inexpensive, generic drug that helps patients prevent dangerously high blood sugar levels, worked nearly twice as long for people who began taking it within three months of their diabetes diagnosis. This is the first study to compare metformin failure rates in a real-world, clinical practice setting... (Source: Health News from Medical News Today)
